Cresilon expands nationwide reach for VETIGEL
through distribution agreements with Midwest Veterinary Supply,
Victor Medical Company, and Penn Veterinary Supply
NEW
YORK, April 24, 2024 /PRNewswire/ -- Cresilon
Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused
on hemostatic medical device technologies, today announced it has
entered into distribution agreements for VETIGEL® to be
sold through several leading regional distributors of veterinary
products and services in the U.S., including Midwest Veterinary
Supply, Victor Medical Company, and Penn Veterinary Supply.
Cresilon's VETIGEL – a revolutionary plant-based hemostatic gel
that instantly stops and controls bleeding – is now available for
veterinary surgeons to purchase directly through Midwest Veterinary
Supply, Victor Medical Company, and Penn Veterinary Supply.
Additionally, VETIGEL is available through national distributors
(as previously announced). For a list of all current distributors,
visit Buy VETIGEL U.S. – VETIGEL Hemostatic Gel.
"Our distribution partnerships will expand our nationwide reach
for VETIGEL and equip more veterinary surgeons with an innovative
hemostatic agent that significantly improves the standard of care
for pets and animals," said Matt
Lewis, Vice President of Sales at Cresilon. "VETIGEL has
been used in over 50,000 surgical procedures thus far and is proven
to reduce blood loss and anesthesia time for patients while helping
veterinary clinics and animal hospitals save time, reduce operating
costs, and improve patient outcomes."
VETIGEL is supplied in a pre-filled syringe, easy-to-use, and
requires no preparation or special storage conditions. Since the
product's debut in 2021, veterinary surgeons across North America, Europe, and Asia have increasingly used VETIGEL as the
fastest and most effective hemostatic agent when treating animals
for traumatic wounds and routine and complex surgical procedures,
including dental extractions, liver biopsies, tumor and mass
removals, cleft palate repairs, and amputations.
VETIGEL offers veterinary surgeons a safe and efficient way to
control animal bleeding across multiple types of bleeds and a wide
range of surgical procedures. The veterinary hemostatic agent
is made of two plant-based polysaccharides that form an instant
mechanical barrier to stop bleeding on contact. Once the bleeding
is controlled, VETIGEL can be easily removed without disturbing the
underlying clot or left in the body to resorb.
In addition to Midwest Veterinary Supply, Victor Medical
Company, and Penn Veterinary Supply, VETIGEL is also available
through several other leading animal health and veterinary product
suppliers in the U.S., including Covetrus, MWI Animal Health, and
Patterson Veterinary Supply.
For more information about VETIGEL, visit www.vetigel.com.
About Cresilon
Cresilon® is a Brooklyn-based biotechnology company that
develops, manufactures, and markets hemostatic medical devices
utilizing the company's proprietary hydrogel technology. The
company's plant-based technology has revolutionized the current
standard by stopping traumatic and surgical bleeds in seconds. The
company's current and future product lines target veterinary, human
trauma, and human surgical applications. Cresilon's mission is to
save lives. For more information about Cresilon, which was recently
named to Fast Company's annual list of the World's Most Innovative
Companies, ranking No. 1 in the medical devices category, visit
www.cresilon.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/vetigel-now-available-through-all-major-us-distributors-of-veterinary-products-and-services-302126485.html
SOURCE Cresilon